Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?

BACKGROUND: A reduced amyloid-β (Aβ)42/40 peptide ratio in blood plasma represents a peripheral biomarker of the cerebral amyloid pathology observed in Alzheimer’s disease brains. The magnitude of the measurable effect in plasma is smaller than in cerebrospinal fluid, presumably due to dilution by A...

Descripción completa

Detalles Bibliográficos
Autores principales: Klafki, Hans-Wolfgang, Morgado, Barbara, Wirths, Oliver, Jahn, Olaf, Bauer, Chris, Esselmann, Hermann, Schuchhardt, Johannes, Wiltfang, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719149/
https://www.ncbi.nlm.nih.gov/pubmed/36461122
http://dx.doi.org/10.1186/s12987-022-00390-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719149/
https://www.ncbi.nlm.nih.gov/pubmed/36461122
http://dx.doi.org/10.1186/s12987-022-00390-4

Ejemplares similares